Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000236:Adenoma / Q000188:drug therapy; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000324:Adrenocorticotropic Hormone; D000328:Adult; D000616:Aminoglutethimide; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D003480:Cushing Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D008797:Metyrapone; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D012636:Secretory Rate
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000925:Anticoagulants; D000616:Aminoglutethimide; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D008797:Metyrapone